Latest News

View allAccessAL amyloidosisCAR-TConferencesMPEMyelomaNewsPatient evidenceVideos

MPE comments on the second implementing act of the EU health technology assessment (HTA) regulation (EU HTAR)

The EU Health Technology Assessment (HTA) Regulation (EU HTAR) entered into force in January 2022 and will be applied starting in January 2025. It aims to improve the availability of medicines and certain medical devices by establishing EU level joint clinical assessments and joint scientific consultations. It also sets rules for the involvement of patients, clinical experts…

Read more

Watch the recording of webinar “AL amyloidosis treatment updates and patient experiences”

Myeloma Patients Europe (MPE) held a webinar to summarise the most important AL amyloidosis updates and share patient experiences with therapies like CAR-T and CAEL-101. The webinar took place on 16th April 2024 and was given by Dr. Moshe Gatt, Physician Researcher Haematologist at the Hebrew University of Jerusalem, Israel, along with two AL Amyloidosis patients from Israel, Naphtali Mastboim…

Read more

MPE launches the Myeloma and AL Amyloidosis European Clinical Trial Navigator

Brussels, 23 April 2024 – Myeloma Patients Europe (MPE) has launched today the English version of the Myeloma and AL Amyloidosis European Clinical Trial Navigator, an online search tool to learn about and find clinical trials for myeloma, monoclonal gammopathy of undetermined significance (MGUS), smouldering multiple myeloma (SMM) and AL amyloidosis in Europe. With this tool, MPE wants to facilitate the search…

Read more

MPE gives feedback on the proposed implementing act supporting the EU Health Technology Assessment regulation

The European Commission recently held an online public consultation on the first draft implementing act supporting the EU health technology assessment (HTA) regulation. The EU HTA regulation will be implemented from 2025 and aims to increase the collaboration on health technology assessment across EU member states. Implementing acts set out the legislative detail of different…

Read more

Sign up for the MPE webinar “AL amyloidosis treatment updates and patient experiences on new therapies”

Myeloma Patients Europe (MPE) will hold the webinar “AL amyloidosis treatment updates and patient experiences on new therapies” on Tuesday 16 April from 17:00 – 18:00 CEST. The webinar will be given by Dr. Moshe Gatt, Physician Researcher Haematologist at the Hebrew University of Jerusalem, Israel, along with two AL Amyloidosis patients from Israel, Naphtali Mastboim and Melvin Granatstein, who…

Read more
May

June 2026

July
MO
TU
WE
TH
FR
SA
SU
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
4
5
Events for 1st June
No Events
Events for 2nd June
No Events
Events for 3rd June
No Events
Events for 4th June
No Events
Events for 5th June
No Events
Events for 6th June
No Events
Events for 7th June
No Events
Events for 8th June
No Events
Events for 9th June
No Events
Events for 10th June
No Events
Events for 11th June
No Events
Events for 12th June
No Events
Events for 13th June
No Events
Events for 14th June
No Events
Events for 15th June
No Events
Events for 16th June
No Events
Events for 17th June
No Events
Events for 18th June
No Events
Events for 19th June
No Events
Events for 20th June
No Events
Events for 21st June
No Events
Events for 22nd June
No Events
Events for 23rd June
No Events
Events for 24th June
No Events
Events for 25th June
No Events
Events for 26th June
No Events
Events for 27th June
No Events
Events for 28th June
No Events
Events for 29th June
No Events
Events for 30th June
No Events